Overview
Headquarters
Greater Los Angeles Area, West Coast, Western US
Capillary Biomedical, Inc. (CapBio) is a medical device startup developing technologies for diabetes management. We aim to dramatically simplify insulin delivery, reducing the burden on both patients and the overall healthcare system. CapBio's first product is the patent-pending SteadiSet infusion set for insulin pump therapy. It's SteadiFlow technology features a kink-proof, super-soft cannula with multi-port delivery designed for reliable and comfortable insulin delivery. Our user-friendly insertion device makes it easy. The company is based in Irvine, CA and is a spin-out of the Artificial Pancreas Center at the Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia, PA. This ongoing academic-industry collaboration is focused on improving the comfort, reliability and predictability of insulin infusion therapy. Together, we aim to achieve more consistent and reliable insulin absorption, which will enable people with diabetes to achieve improved blood glucose control. Capillary Biomedical, Inc. operates as a medical device company. The Company focuses on developing novel technologies leading to an artificial pancreas system that will simplify diabetes management and reduce the burden on patients. Capillary Biomedical serves customers in the United States. Capillary Biomedical is a medical device startup developing technologies for diabetes management.
